Welcome to Targanta Therapeutics Print Page
Adel Rafai Far, Ph.D.
Director, Chemistry Research

Adel Rafai Far joined Targanta Therapeutics in May 2003 and is currently leading the internal medicinal and bioanalytical chemistry effort. He is responsible for the optimization of the medicinal properties of compounds advancing through the internal programs of the company. He has received his PhD degree in organic chemistry from the University of Toronto (Toronto, Canada) and has carried postdoctoral research at the Scripps Research Institute (LaJolla, California). Prior to joining Targanta, Dr. Rafai Far was employed at GlycoDesign Inc., a company developing proprietary drugs for cancer treatment and the prevention of cardiovascular and chronic inflammatory diseases based on recent progresses in glycobiology.